Immunology: Studying CD38's role in immune cell function and its potential as a biomarker for immune-related diseases. Oncology: Investigating CD38-targeted therapies for cancers, particularly hematological malignancies. Metabolism: Exploring CD38's involvement in metabolic pathways and its implications in metabolic disorders.